Disposition of 4363 shares by Rebecca Buzzeo of Maravai Lifesciences at 4.42 subject to Rule 16b-3

MRVI Stock  USD 5.22  0.26  5.24%   
Under 56% of all Maravai Lifesciences' traders are looking to take a long position. The analysis of overall sentiment of trading Maravai Lifesciences Holdings stock suggests that some investors are interested at this time. Maravai Lifesciences' investing sentiment shows overall attitude of investors towards Maravai Lifesciences Holdings.
  
Filed transaction by Maravai Lifesciences Holdings Officer: See Remarks. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at gurufocus.com
Gurufocus Stories at Macroaxis
  
Disposition of 4363 class a common stock at 4.42 of Maravai Lifesciences by Rebecca Buzzeo on 15th of November 2024. This event was filed by Maravai Lifesciences Holdings with SEC on 2024-11-15. Statement of changes in beneficial ownership - SEC Form 4

Maravai Lifesciences Fundamental Analysis

We analyze Maravai Lifesciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Maravai Lifesciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Maravai Lifesciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Return On Equity

Return On Equity Comparative Analysis

Maravai Lifesciences is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Maravai Lifesciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Maravai Lifesciences stock to make a market-neutral strategy. Peer analysis of Maravai Lifesciences could also be used in its relative valuation, which is a method of valuing Maravai Lifesciences by comparing valuation metrics with similar companies.

Peers

Maravai Lifesciences Related Equities

PTGXProtagonist Therapeutics   11.55   
0%
100.0%
APLSApellis Pharmaceuticals   10.88   
0%
94.0%
HALOHalozyme Therapeutics   7.22   
0%
62.0%
ROIVRoivant Sciences   6.01   
0%
52.0%
ASNDAscendis Pharma   5.85   
0%
50.0%
AKROAkero Therapeutics   4.90   
0%
42.0%
ALECAlector   4.79   
0%
41.0%
KRYSKrystal Biotech   4.45   
0%
38.0%
CYTKCytokinetics   3.00   
0%
25.0%
LEGNLegend Biotech   2.99   
0%
25.0%
RAREUltragenyx   2.65   
0%
22.0%
HRMYHarmony Biosciences   2.53   
0%
21.0%
DNLIDenali Therapeutics   1.94   
0%
16.0%
INCYIncyte   1.89   
0%
16.0%
FOLDAmicus Therapeutics   1.68   
0%
14.0%
ARGXArgenx NV   1.54   
0%
13.0%
ABUSArbutus Biopharma   1.45   
0%
12.0%
IMVTImmunovant   1.24   
0%
10.0%
EWTXEdgewise Therapeutics   0.69   
0%
5.0%
AGIOAgios Pharm   0.25   
0%
2.0%
INSMInsmed   0.89   
7.0%
0%
ARQTArcutis Biotherapeutics   0.98   
8.0%
0%

Complementary Tools for Maravai Stock analysis

When running Maravai Lifesciences' price analysis, check to measure Maravai Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maravai Lifesciences is operating at the current time. Most of Maravai Lifesciences' value examination focuses on studying past and present price action to predict the probability of Maravai Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maravai Lifesciences' price. Additionally, you may evaluate how the addition of Maravai Lifesciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets